By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Life Care NewsLife Care NewsLife Care News
  • Home
  • Business
    • Business
  • News
  • Tech
  • Entertainment
  • Health
  • Education
  • Automobile
  • Sports
Search
Technology
  • Advertise
  • Advertise
Health
Entertainment
  • Home
  • Business
    • Business
  • News
  • Tech
  • Entertainment
  • Health
  • Education
  • Automobile
  • Sports
  • Advertise
  • Advertise
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved.
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Reading: Ibex Biosciences Launches Regulation D Campaign on Fundable
Share
Notification Show More
Font ResizerAa
Life Care NewsLife Care News
Font ResizerAa
  • Education
  • Automobile
  • Entertainment
  • News
  • Tech
  • Sports
Search
  • Home
  • Home
    • Home 1
    • Default Home 5
  • Categories
  • Categories
    • Tech
    • Entertainment
    • Automobile
    • Sports
    • Education
    • News
    • Health
  • Bookmarks
  • Bookmarks
  • More Foxiz
    • Sitemap
  • More Foxiz
    • Sitemap
Follow US
  • Advertise
  • Advertise
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Tech

Ibex Biosciences Launches Regulation D Campaign on Fundable

GlobeNews Wire
Last updated: 04/02/2025 4:55 AM
GlobeNews Wire
Share
2 Min Read
Ibex Biosciences Launches Regulation D Campaign on Fundable
SHARE
Ibex Biosciences Launches Regulation D Campaign on Fundable

North Bethesda, Maryland, Feb. 03, 2025 (GLOBE NEWSWIRE) — This recent move opens up investment opportunities for accredited investors looking to support cutting-edge research in antibodies, regeneration, and gene therapies.

The company stands out in the biotech landscape with its commitment to developing potential therapies without relying on external acquisitions. It has a robust pipeline of unique preclinical programs, further positioning it at the forefront of addressing numerous health issues currently affecting mankind like Malaria and numerous cancers. 

Key Highlights of Ibex Biosciences:

  • Antibody Research: Preclinical therapeutic antibody programs targeting Malaria and Oncology, with potential applications in treating inflammatory conditions.
  • Regenerative Platform: A unique approach that utilizes gene therapy to facilitate a functional repair of damaged cells in situ. Ibex holds a patent for a transcription factor aimed at fostering regeneration while inhibiting oncogenesis.
  • Gene Therapy Programs: Multiple preclinical gene therapy programs focus on the direct targeting of cancerous tumors and the mitigation of both chronic and acute inflammation. 

The company’s objectives include proactively identifying and assessing novel molecules and innovative methods for developing more potent therapeutics, as well as seeking out pioneering scientists and their early-stage discoveries to further product development objectives.

Investors in Ibex Biosciences will support a company on the cutting edge of biotech research. The company’s approach of developing therapies from scratch offers a unique value proposition in the biotech investment landscape.

For more information about Ibex Biosciences and its Regulation D campaign on Fundable, please visit their campaign. 

A. Murat Croci
Co-CEO — Cofounder/Operations
Ibex Biosciences, Inc.
Website: www.ibex.bio

 

You Might Also Like

#SnowStories: How Kristne Cera coaches and inspires the next generation of skiers in Latvia

Cerebras Delivers Record-Breaking Performance with Meta’s Llama 3.1 405B Model

Bolys High Performance Concentrated Solar Products Move into Mass Production

Renowned Madagascar Scientist, Explorer and Mentor Named Winner of World’s Leading Animal Conservation Award

5MW Standard Container Design: Trina Hydrogen’s Innovative Hydrogen Equipment Supports Global Energy Transition

TAGGED:accreditedantibodiesbethesdabiosciencesbiotechcampaigncommitmentcompanycuttingedgedevelopingfebfundablegeneglobeibexinvestmentinvestorsLandscapelauncheslookingmarylandmovenewswirenorthnumerousopensopportunitiespotentialrecentregenerationregulationResearchstandssupporttherapiesuncategorizedwithout

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Share
Previous Article BlackFort: Bridging the Gap to a Decentralized Future BlackFort: Bridging the Gap to a Decentralized Future
Next Article dLocal to Report Fourth Quarter 2024 Financial Results dLocal to Report Fourth Quarter 2024 Financial Results

Stay Connected

FacebookLike
TwitterFollow
PinterestPin
InstagramFollow
YoutubeSubscribe
Google NewsFollow
LinkedInFollow
MediumFollow
- Advertisement -

Latest News

Green NCAP & CATARC strengthen cooperation in new Working Group & LCA Mutual Recognition Guidelines
Automobile 12/06/2025
Bay Area Lyme Foundation Announces National Winner of the 2025 Emerging Leader Award to Develop a Much-Needed Rapid, Low-Cost, Easy-to-Use Lyme Disease Test
Bay Area Lyme Foundation Announces National Winner of the 2025 Emerging Leader Award to Develop a Much-Needed Rapid, Low-Cost, Easy-to-Use Lyme Disease Test
Health 12/06/2025
Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics
Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics
Health 12/06/2025
Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements
Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements
Health 12/06/2025
//

We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

Quick Link

  • About Us
  • Contact Us
  • Editorial Guidelines
  • Privacy Policy
  • Terms and Conditions

Top Categories

  • Automobile
  • Education
  • Entertainment
  • Health
  • News
  • Sports
  • Tech

Sign Up for Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

Life Care NewsLife Care News
Follow US
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..

Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?